Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) - Total Assets
Based on the latest financial reports, Shandong Weigao Orthopaedic Device Co. Ltd. A (688161) holds total assets worth CN¥5.19 Billion CNY (≈ $759.56 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 688161 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Shandong Weigao Orthopaedic Device Co. Ltd. A - Total Assets Trend (2019–2025)
This chart illustrates how Shandong Weigao Orthopaedic Device Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. See net assets of Shandong Weigao Orthopaedic Device Co. L for net asset value and shareholders' equity analysis.
Shandong Weigao Orthopaedic Device Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2025)
Shandong Weigao Orthopaedic Device Co. Ltd. A's total assets of CN¥5.19 Billion consist of 85.1% current assets and 14.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 27.1% |
| Accounts Receivable | CN¥288.88 Million | 5.7% |
| Inventory | CN¥589.30 Million | 11.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥90.35 Million | 1.8% |
| Goodwill | CN¥34.36 Million | 0.7% |
Asset Composition Trend (2019–2025)
This chart illustrates how Shandong Weigao Orthopaedic Device Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Shandong Weigao Orthopaedic Device Co. L.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shandong Weigao Orthopaedic Device Co. Ltd. A's current assets represent 85.1% of total assets in 2025, an increase from 81.7% in 2019.
- Cash Position: Cash and equivalents constituted 27.1% of total assets in 2025, down from 56.4% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 3.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 11.6% of total assets.
Shandong Weigao Orthopaedic Device Co. Ltd. A Competitors by Total Assets
Key competitors of Shandong Weigao Orthopaedic Device Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩83.86 Billion |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €62.52 Million |
|
ORTOMA AB B
F:82Y
|
Germany | €161.34 Million |
|
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM
|
USA | $101.85 Million |
|
Allmed Solutions Ltd
TA:ALMD
|
Israel | ILA31.54 Million |
|
Universal Biosensors Inc
AU:UBI
|
Australia | AU$14.94 Million |
Shandong Weigao Orthopaedic Device Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.76 | 5.14 | 6.51 |
| Quick Ratio | 4.07 | 4.32 | 5.69 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥3.43 Billion | CN¥3.39 Billion | CN¥4.05 Billion |
Shandong Weigao Orthopaedic Device Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Shandong Weigao Orthopaedic Device Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.76 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | 2.3% |
| Total Assets | CN¥5.06 Billion |
| Market Capitalization | $1.26 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Shandong Weigao Orthopaedic Device Co. Ltd. A's assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Shandong Weigao Orthopaedic Device Co. Ltd. A's assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Shandong Weigao Orthopaedic Device Co. Ltd. A (2019–2025)
The table below shows the annual total assets of Shandong Weigao Orthopaedic Device Co. Ltd. A from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥5.06 Billion ≈ $740.59 Million |
+2.28% |
| 2024-12-31 | CN¥4.95 Billion ≈ $724.05 Million |
-2.91% |
| 2023-12-31 | CN¥5.10 Billion ≈ $745.79 Million |
-15.28% |
| 2022-12-31 | CN¥6.02 Billion ≈ $880.29 Million |
+11.33% |
| 2021-12-31 | CN¥5.40 Billion ≈ $790.67 Million |
+69.54% |
| 2020-12-31 | CN¥3.19 Billion ≈ $466.35 Million |
-0.80% |
| 2019-12-31 | CN¥3.21 Billion ≈ $470.11 Million |
-- |
About Shandong Weigao Orthopaedic Device Co. Ltd. A
Shandong Weigao Orthopaedic Device Co., Ltd. engages in research, development, production, and sales of orthopedic medical devices. The company offers orthopedic implantable medical devices and orthopedic surgical instruments. It also provides spinal products, such as internal fixation systems for the cervical and thoracic/lumbar spine, and interbody fusion devices; trauma-related products includ… Read more